Progenics Pharmaceuticals, Inc. (13)
Browse by Contract Category
Contracts
-
Bridge Loan Agreement, dated as of March 15, 2020, between Progenics Pharmaceuticals, Inc. and Lantheus Medical Imaging, Inc
(Filed With SEC on March 16, 2020)
-
Employment Offer Letter Agreement between the Registrant and Asha Das
(Filed With SEC on March 13, 2020)
-
Amended and Restated Agreement and Plan of Merger, dated as of February 20, 2020, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc
(Filed With SEC on February 20, 2020)
-
Description of Capital Stock
(Filed With SEC on March 13, 2020)
-
Employment Offer Letter Agreement between the Registrant and Benedict Osorio
(Filed With SEC on March 13, 2020)
-
Employment Offer Letter Agreement between the Registrant and Bryce Tenbarge
(Filed With SEC on March 13, 2020)
-
Consulting Services Agreement, dated November 15, 2019, between the Registrant and David Mims
(Filed With SEC on March 13, 2020)
-
Form of Retention Bonus Agreement
(Filed With SEC on March 13, 2020)
-
Consulting Services Agreement, dated as of March 4, 2020, by and between Progenics Pharmaceuticals, Inc. and Patrick Fabbio
(Filed With SEC on March 4, 2020)
-
Form of Non-Qualified Stock Option Award Agreement for Directors under the 2018 Performance Incentive Plan
(Filed With SEC on November 7, 2019)
-
Form of Non-Qualified Stock Option Award Agreement for Employees under the 2018 Performance Incentive Plan
(Filed With SEC on November 7, 2019)
-
Agreement and Plan of Merger, dated as of October 1, 2019, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc
(Filed With SEC on October 2, 2019)
-
Amendment to the Stock Purchase and Sale Agreement, dated May 9, 2019, by and between Progenics Pharmaceuticals, Inc., Molecular Insight Pharmaceuticals, Inc., and Highland...
(Filed With SEC on May 14, 2019)